| NAD(+) metabolism-based immunoregulation and therapeutic potential |
| 論文作者 |
Fang, JK; Chen, WW; Hou, PB; Liu, ZH; Zuo, MQ; Liu, SS; Feng, C; Han, YY; Li, PS; Shi, YF; Shao, CS |
| 期刊/會(huì)議名稱 |
CELL AND BIOSCIENCE |
| 論文年度 |
2023 |
| 論文類別 |
Review |
| 摘要 |
Nicotinamide adenine dinucleotide (NAD(+)) is a critical metabolite that acts as a cofactor in energy metabolism, and serves as a cosubstrate for non-redox NAD(+)-dependent enzymes, including sirtuins, CD38 and poly(ADP-ribose) polymerases. NAD(+) metabolism can regulate functionality attributes of innate and adaptive immune cells and contribute to inflammatory responses. Thus, the manipulation of NAD(+) bioavailability can reshape the courses of immunological diseases. Here, we review the basics of NAD(+) biochemistry and its roles in the immune response, and discuss current challenges and the future translational potential of NAD(+) research in the development of therapeutics for inflammatory diseases, such as COVID-19. |
| 期 |
1 |
| 卷 |
13 |
| 影響因子 |
7.5 |
官方微信
